BGD
BIOGENED
NEWCONNECT
LISTED
Shareholders
as of September 20, 2026 · source: notifications under Art. 69 of the Offering Act · 3 entities above 5%
FREE FLOAT
The portion of capital not covered by notifications above 5% — its composition is not publicly known.
5.89%
—
LARGEST STAKE
40.9%
ENRAV Fundacja Rodzinna
TOP 3 CONCENTRATION
Combined stake of the three largest shareholders above the 5% threshold.
94.11%
3 entities above 5%
LATEST CHANGE
June 25, 2026
ESPI (wykaz z WZ)
Ownership structure
stakes per latest notifications
SHAREHOLDERS ≥5% 94.11%
FREE FLOAT 5.89%
HOLDER
STAKE
SHARES
VOTES
NOTIFICATION
ENRAV Fundacja Rodzinna
40.9%
1,004,555
40.9%
August 16, 2026
Life Science Technologies N.V.
36.93%
907,050
36.93%
August 16, 2026
BIONIQ LIMITED
16.28%
400,000
16.28%
August 16, 2026
Other
5.89%
—
5.89%
—
ENRAV Fundacja Rodzinna
40.9%
1,004,555 shares · notification August 16, 2026
Life Science Technologies N.V.
36.93%
907,050 shares · notification August 16, 2026
BIONIQ LIMITED
16.28%
400,000 shares · notification August 16, 2026
Other
5.89%
— · composition undisclosed
Notification history
crossings above/below the 5% / 10% / 20% thresholdsJune 25, 2026
ESPI (wykaz z WZ) — baseline reading
Life Science Technologies N.V.:
new in the registry, 36.93%
→
Capital and votes
Number of shares
—
ISIN
PLBIOGN00018
Sector
Produkcja Leków
Market
NEWCONNECT
Country
PL
Listing date
May 17, 2026
Where this data comes from
The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.
Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.
Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.